We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KW
2951
DELISTED
Kennedy-Wilson Holdings
KW
$7K ﹤0.01%
312
-5,202
-94% -$102K
LARK icon
2952
Landmark Bancorp
LARK
$195M
$7K ﹤0.01%
347
+35
+11% +$673
MCS icon
2953
Marcus Corp
MCS
$945M
$7K ﹤0.01%
213
-745
-78% -$23.5K
MLAB icon
2954
Mesa Laboratories
MLAB
$574M
$7K ﹤0.01%
+35
New +$6.12K
MTRX icon
2955
Matrix Service
MTRX
$335M
$7K ﹤0.01%
380
-1,370
-78% -$23.7K
NWFL icon
2956
Norwood Financial Corp
NWFL
$368M
$7K ﹤0.01%
+194
New +$6.12K
OFG icon
2957
OFG Bancorp
OFG
$2.21B
$7K ﹤0.01%
530
-23,527
-98% -$318K
PFLT icon
2958
PennantPark Floating Rate Capital
PFLT
$746M
$7K ﹤0.01%
499
-596
-54% -$8.07K
PJT icon
2959
PJT Partners
PJT
$4.38B
$7K ﹤0.01%
+139
New +$7.61K
PNRG icon
2960
PrimeEnergy Resources
PNRG
$298M
$7K ﹤0.01%
101
+21
+26% +$1.39K
PROV icon
2961
Provident Financial
PROV
$112M
$7K ﹤0.01%
380
+275
+262% +$5.05K
PTGX icon
2962
Protagonist Therapeutics
PTGX
$9.44B
$7K ﹤0.01%
1,047
-247
-19% -$1.9K
RGCO icon
2963
RGC Resources
RGCO
$228M
$7K ﹤0.01%
223
-77
-26% -$2.05K
SBGI icon
2964
Sinclair Inc
SBGI
$1.03B
$7K ﹤0.01%
232
-1,586
-87% -$47.5K
SIGI icon
2965
Selective Insurance
SIGI
$5.73B
$7K ﹤0.01%
+136
New +$7.89K
SUPV
2966
Grupo Supervielle
SUPV
$753M
$7K ﹤0.01%
661
+46
+7% +$1K
TANH icon
2967
Tantech Holdings
TANH
$6.1M
-1
Closed -$30.3K
TU icon
2968
Telus
TU
$15.3B
$7K ﹤0.01%
376
-6,744
-95% -$119K
URGN icon
2969
UroGen Pharma
URGN
$2.29B
$7K ﹤0.01%
138
-59
-30% -$3.43K
VT icon
2970
Vanguard Total World Stock ETF
VT
$79.8B
$7K ﹤0.01%
+100
New +$7.46K
WPRT
2971
Westport Fuel Systems
WPRT
$35.7M
$7K ﹤0.01%
290
-1,033
-78% -$26K
NVRO
2972
DELISTED
NEVRO CORP.
NVRO
$7K ﹤0.01%
90
-651
-88% -$54K
SBT
2973
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$7K ﹤0.01%
+559
New +$7.56K
RVNC
2974
DELISTED
Revance Therapeutics, Inc.
RVNC
$7K ﹤0.01%
+246
New +$7.39K
OSG
2975
DELISTED
Overseas Shipholding Group Inc.
OSG
$7K ﹤0.01%
1,770
-1,490
-46% -$5.37K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.